Northern Trust Corp Has $7.62 Million Stock Holdings in Aspen Aerogels, Inc. (NYSE:ASPN)

Northern Trust Corp lifted its holdings in shares of Aspen Aerogels, Inc. (NYSE:ASPN) by 13.7% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 641,050 shares of the construction company’s stock after buying an additional 77,364 shares during the period. Northern Trust Corp’s holdings in Aspen Aerogels were worth $7,616,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of the business. Vanguard Group Inc. boosted its stake in shares of Aspen Aerogels by 5.5% during the 4th quarter. Vanguard Group Inc. now owns 4,360,246 shares of the construction company’s stock worth $51,800,000 after buying an additional 226,251 shares during the last quarter. Dimensional Fund Advisors LP lifted its stake in Aspen Aerogels by 25.5% in the 4th quarter. Dimensional Fund Advisors LP now owns 2,018,631 shares of the construction company’s stock valued at $23,983,000 after purchasing an additional 409,862 shares during the last quarter. Telemark Asset Management LLC lifted its stake in Aspen Aerogels by 26.8% in the 4th quarter. Telemark Asset Management LLC now owns 1,892,424 shares of the construction company’s stock valued at $22,482,000 after purchasing an additional 400,000 shares during the last quarter. Geode Capital Management LLC lifted its stake in Aspen Aerogels by 5.6% in the 4th quarter. Geode Capital Management LLC now owns 1,464,163 shares of the construction company’s stock valued at $17,398,000 after purchasing an additional 78,195 shares during the last quarter. Finally, Dendur Capital LP acquired a new stake in Aspen Aerogels in the 4th quarter valued at about $9,207,000. 97.64% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

ASPN has been the subject of several recent analyst reports. Canaccord Genuity Group cut their target price on shares of Aspen Aerogels from $20.00 to $15.00 and set a “buy” rating for the company in a research note on Friday, February 14th. StockNews.com upgraded shares of Aspen Aerogels to a “sell” rating in a research note on Wednesday, February 19th. Barclays cut their target price on shares of Aspen Aerogels from $25.00 to $13.00 and set an “overweight” rating for the company in a research note on Wednesday, February 19th. B. Riley cut their target price on shares of Aspen Aerogels from $35.00 to $22.00 and set a “buy” rating for the company in a research note on Wednesday, February 19th. Finally, TD Cowen upgraded shares of Aspen Aerogels to a “strong-buy” rating in a research note on Tuesday, March 11th. One analyst has rated the stock with a sell rating, two have issued a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $19.11.

Aspen Aerogels Trading Up 12.0%

ASPN opened at $6.38 on Monday. Aspen Aerogels, Inc. has a 1-year low of $4.16 and a 1-year high of $33.15. The company has a current ratio of 2.93, a quick ratio of 2.48 and a debt-to-equity ratio of 0.27. The company has a market cap of $523.42 million, a P/E ratio of 39.85 and a beta of 2.72. The company has a fifty day moving average price of $5.89 and a two-hundred day moving average price of $10.02.

Aspen Aerogels (NYSE:ASPN) last posted its quarterly earnings results on Thursday, May 8th. The construction company reported ($0.06) earnings per share for the quarter, beating the consensus estimate of ($0.07) by $0.01. The firm had revenue of $78.72 million during the quarter, compared to the consensus estimate of $82.75 million. Aspen Aerogels had a net margin of 2.95% and a return on equity of 7.49%. The business’s revenue was down 16.7% compared to the same quarter last year. During the same period in the previous year, the firm posted ($0.02) earnings per share. Analysts predict that Aspen Aerogels, Inc. will post 0.17 EPS for the current fiscal year.

Insider Buying and Selling

In other news, CEO Donald R. Young purchased 20,000 shares of the business’s stock in a transaction that occurred on Monday, May 12th. The shares were acquired at an average cost of $5.35 per share, for a total transaction of $107,000.00. Following the completion of the acquisition, the chief executive officer now owns 550,856 shares in the company, valued at $2,947,079.60. This trade represents a 3.77% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. 4.30% of the stock is owned by corporate insiders.

Aspen Aerogels Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.